已收录 272983 条政策
 政策提纲
  • 暂无提纲
Photoletter to the editor: Topical 0.5% brimonidine gel to camouflage redness of immature scars
[摘要] Cutaneous scars develop as a result of a defective wound healing process. Scars are commonly visible as erythematous, sometimes disfiguring lesions which might be stigmatizing for the affected patient. Only a few therapies to improve the appearance of scars are available. Recently, brimonidine — a selective α2-receptor-agonist which causes vasoconstriction of small cutaneous vessels — was approved for the treatment of erythemato-telangiectatic rosacea. Topical brimonidine might also be helpful to improve redness of immature scars. Here we report on the effect of brimonidine 0.5% gel on a flat, erythematous scar in a 25-year-old female patient. Whitening of the scar could be observed immediately after application of brimonidine 0.5% gel and a good clinical result was observed within one hour. This effect lasted for up to three hours. We conclude that brimonidine 0.5% gel is a suitable topical therapy to reduce erythema in visible cutaneous scars.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 皮肤病学
[关键词] brimonidine gel;erythema;immature scar;scar;topical therapy [时效性] 
   浏览次数:10      统一登录查看全文      激活码登录查看全文